Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Elevance Health (ELV)
NYSE:ELV
ELV Analyst Ratings
Moderate Buy
11 Buy
4 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ELV Stock 12 Month Forecast
Average Price Target
$472.38
▲(20.59% Upside)
| Highest Price Target$512.00 | Average Price Target$472.38 | Lowest Price Target$405.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Cantor Fitzgerald
Reiterated
02/19/25
Morgan Stanley
Reiterated
02/04/25
J.P. Morgan
Reiterated
01/28/25
Argus Research
Assigned
01/28/25
Wells Fargo
Reiterated
01/28/25
Jefferies
Reiterated
01/27/25
Bernstein
Reiterated
01/27/25
TD Cowen
Assigned
01/27/25
Truist Financial
Reiterated
01/24/25
Bank of America Securities
Assigned
01/24/25
Barclays
$501→$512
Buy
30.71%
Upside
Reiterated
01/24/25
Barclays Remains a Buy on Elevance Health (ELV)
Mizuho Securities
―
Buy
―
Reiterated
01/23/25
Ann Hynes Recommends 'Buy' on Elevance Health Due to Strong Growth Potential and Strategic Guidance
Leerink Partners
$463
Buy
18.20%
Upside
Reiterated
01/23/25
Elevance Health: Attractive Valuation and Stable Growth Prospects Drive Buy RatingWe lower our price target to $463 (from $515). We lower our price target to $463 based on a 13.5x (from 14.8x) P/E multiple applied to our 2025 EPS estimate of $34.31 (from $34.63). We substantiate that as a slight discount to its historical 14x averages on below-average earnings visibility and elevated cost trend pressure.
RBC Capital
$478
Buy
22.03%
Upside
Reiterated
01/23/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Elevance Health (NYSE: ELV), Intuitive Surgical (NASDAQ: ISRG) and Walgreens Boots Alliance (NASDAQ: WBA)
Stephens
$440
Hold
12.33%
Upside
Downgraded
01/22/25
Elevance Health Faces Significant Risks and Uncertainties Leading to Hold Rating
Best Analysts Covering Elevance Health
Which Analyst Should I Follow If I Want to Buy ELV and Sell After:
1 Month
xxx
Success Rate
13/22 ratings generated profit
Average Return
+1.30%
reiterated a xxx
rating 30 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 59.09% of your transactions generating a profit, with an average return of +1.30% per trade.
3 Months
xxx
Success Rate
21/38 ratings generated profit
Average Return
+0.74%
reiterated a xxx
rating 26 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 55.26% of your transactions generating a profit, with an average return of +0.74% per trade.
1 Year
2 Years
xxx
Success Rate
24/27 ratings generated profit
Average Return
+44.34%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 88.89% of your transactions generating a profit, with an average return of +44.34% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ELV Analyst Recommendation Trends
Rating
Oct 24
Nov 24
Dec 24
Jan 25
Feb 25
Strong Buy
0
0
0
0
0
Buy
19
19
20
19
18
Hold
2
2
2
4
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
21
21
22
23
23
Each month's total comprises the sum of three months' worth of ratings.
ELV Financial Forecast
ELV Stock Forecast FAQ
What is ELV’s average 12-month price target, according to analysts?
Based on analyst ratings, Elevance Health’s 12-month average price target is $472.38.
What is ELV’s upside potential, based on the analysts’ average price target?
Elevance Health has 20.59% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ELV a Buy, Sell or Hold?
Elevance Health has a consensus rating of Moderate Buy which is based on 11 buy ratings, 4 hold ratings and 0 sell ratings.
What is Elevance Health’s price target?
The average price target for Elevance Health is $472.38. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $512.00 ,the lowest forecast is $405.00. The average price target represents 20.59% Increase from the current price of $391.71.
The highest analyst price target is $512.00 ,the lowest forecast is $405.00. The average price target represents 20.59% Increase from the current price of $391.71.
What do analysts say about Elevance Health?
Elevance Health’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 15 Wall Streets Analysts.
How can I buy shares of ELV?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.